- Home
- CORT vs HSIC Comparison
CORT vs HSIC Comparison
Compare CORT & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- HSIC
- Stock Information
- Founded
- CORT 1998
- HSIC 1932
- Country
- CORT United States
- HSIC United States
- Employees
- CORT N/A
- HSIC N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- HSIC Medical Specialities
- Sector
- CORT Health Care
- HSIC Health Care
- Exchange
- CORT Nasdaq
- HSIC Nasdaq
- Market Cap
- CORT 7.6B
- HSIC 8.4B
- IPO Year
- CORT N/A
- HSIC 1995
- Fundamental
- Price
- CORT $75.18
- HSIC $67.37
- Analyst Decision
- CORT Strong Buy
- HSIC Buy
- Analyst Count
- CORT 4
- HSIC 12
- Target Price
- CORT $139.00
- HSIC $76.25
- AVG Volume (30 Days)
- CORT 675.5K
- HSIC 1.4M
- Earning Date
- CORT 10-29-2025
- HSIC 11-04-2025
- Dividend Yield
- CORT N/A
- HSIC N/A
- EPS Growth
- CORT N/A
- HSIC 15.03
- EPS
- CORT 1.11
- HSIC 3.11
- Revenue
- CORT $716,080,000.00
- HSIC $12,773,000,000.00
- Revenue This Year
- CORT $30.62
- HSIC $4.62
- Revenue Next Year
- CORT $37.68
- HSIC $3.55
- P/E Ratio
- CORT $67.23
- HSIC $21.76
- Revenue Growth
- CORT 25.71
- HSIC 2.29
- 52 Week Low
- CORT $38.68
- HSIC $60.56
- 52 Week High
- CORT $117.33
- HSIC $82.49
- Technical
- Relative Strength Index (RSI)
- CORT 60.68
- HSIC 44.81
- Support Level
- CORT $69.03
- HSIC $66.98
- Resistance Level
- CORT $74.79
- HSIC $70.69
- Average True Range (ATR)
- CORT 2.69
- HSIC 1.69
- MACD
- CORT 0.32
- HSIC 0.02
- Stochastic Oscillator
- CORT 95.68
- HSIC 18.63
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.